Poly(ADP-ribose)-dependent TDP-43 pathology in oxidative stress (R21)

氧化应激中聚 (ADP-核糖) 依赖性 TDP-43 病理学 (R21)

基本信息

  • 批准号:
    10753095
  • 负责人:
  • 金额:
    $ 40.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-01 至 2025-08-31
  • 项目状态:
    未结题

项目摘要

Abstract Frontotemporal dementia (FTD) is an Alzheimer-related dementia disease (ADRD) and involves nuclear egress and cytoplasmic Transactivation response DNA binding protein 43 (TDP-43). The mechanisms for pathological export of TDP-43 or its accumulation in the cytoplasm is not clearly defined. Although, studies on disease-causing mutations have revealed that defects in nuclear import may be in part responsible for TDP-43 accumulation in the cytosol as these mutations change the properties of the protein. However, it remains largely unclear how TDP-43 accumulates in the cytosol, as the majority of the TDP-43 dependent pathologies are sporadic. TDP-43 contains two RNA recognition motifs (RRMs), a nuclear export signal (NES), and a nuclear localization signal (NLS) in its N-terminus, and binds poly (ADP-ribose) polymer (PAR) via a PAR-binding motif embedded in its NLS. Studies have shown that PAR inhibitors can inhibit TDP-43 pathology, and binding of PAR to TDP-43 can change its biophysical characteristics in solution. Exportin 1 (XPO1) mediates the NES-dependent export of proteins from the nucleus. TDP-43 is a 43kDa protein that may not require XPO1-dependent export under basal conditions but our data indicates that under neuronal stress conditions TDP-43 egresses the nucleus via XPO-1 dependent export. We hypothesize that in disease conditions like FTD type ADRD and related diseases; PAR binds TDP-43 in the nucleus and facilitates its interaction with XPO-1, which subsequently enhances the egress of TDP-43 from the nucleus to cytosol. This proposal is supported our preliminary data that both PARP inhibitor BMN673 and XPO-1 inhibitor KPT- 185 inhibit the cytosolic accumulation of TDP-43 in neurons and TDP-43 and XPO1 interact following PARP activation. In this proposal, we plan to study the alterations in TDP-43 in mouse cortical neurons exposed to oxidative stress. Oxidative stress is a common pathological process mediating protein mislocalization, aggregation, and cell death in virtually all neurological disorders including FTD. Oxidative stress via H2O2 in cortical neurons mediates a robust TDP-43 cytosolic localization. Therefore, it is likely that pathophysiological mechanisms identified in the oxidative stress model in cortical neurons can closely overlap/mimic pathological mechanisms in FTD and other ADRD involving changes/mislocalization of TDP-43. We will use biochemical, cell biological and imaging techniques in combination with proximity ligation assays, CryoEM, and Hydrogen/Deuterium Exchange mass spectrometry to assess the PAR-dependent alteration in TDP-43 and its interaction with XPO-1 that leads to an increase in the release of TDP-43 from the nucleus and subsequent accumulation/aggregation in the cytoplasm. These studies will help in understanding the pathophysiological mechanisms of TDP-43 accumulation in FTD, ALS, and other ADRD/dementia related diseases involving TDP-43
抽象的 额颞痴呆(FTD)是阿尔茨海默氏症相关痴呆症(ADRD),涉及核 出口和细胞质反式反应反应DNA结合蛋白43(TDP-43)。机制 TDP-43的病理出口或其在细胞质中的积累尚未明确定义。虽然,研究 关于引起疾病的突变表明,核进口缺陷可能部分是为了 当这些突变改变蛋白质的特性时,TDP-43在细胞质中积累。但是,它 仍然不清楚TDP-43如何在细胞质中积聚,因为大多数TDP-43依赖 病理是零星的。 TDP-43包含两个RNA识别基序(RRMS),一个核输出信号 (NES)和其N末端中的核定位信号(NLS),并结合聚(ADP-核糖)聚合物(PAR) 通过嵌入其NLS中的Par结合基序。研究表明,PAR抑制剂可以抑制TDP-43 PAR与TDP-43与TDP-43的结合可以改变其在溶液中的生物物理特征。导出1 (XPO1)介导了核中NES依赖性蛋白的导出。 TDP-43是一种43KDA蛋白 在基础条件下可能不需要XPO1依赖性导出,但我们的数据表明在神经元下 应力条件TDP-43通过XPO-1依赖性输出来排出核。我们假设在疾病中 诸如FTD类型ADRD和相关疾病之类的疾病; PAR在细胞核中结合TDP-43并促进其 与XPO-1的相互作用,随后增强了TDP-43从细胞核到细胞质的出口。 该建议得到了我们的初步数据,即PARP抑制剂BMN673和XPO-1抑制剂KPT- 185抑制神经元中TDP-43的胞质积累,TDP-43和XPO1在PARP之后相互作用 激活。在此提案中,我们计划研究暴露于小鼠皮质神经元中TDP-43的改变 氧化应激。氧化应激是介导蛋白质错误的常见病理过程, 几乎所有神经系统疾病(包括FTD)的聚集和细胞死亡。通过H2O2氧化应激 皮质神经元介导了强大的TDP-43胞质定位。因此,病理生理可能 皮质神经元中氧化应激模型中鉴定出的机制可以紧密重叠/模拟病理 FTD和其他ADRD的机制,涉及TDP-43的变化/错误定位。 我们将使用生化,细胞生物学和成像技术与接近连接分析结合使用, 冷冻和氢/氘交换质谱法,以评估依赖性的变化 TDP-43及其与XPO-1的相互作用导致TDP-43从核中释放的增加 并随后在细胞质中积累/聚集。这些研究将有助于理解 FTD,ALS和其他ADRD/痴呆相关的TDP-43积累的病理生理机制 涉及TDP-43的疾病

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Shaida A. Andrabi其他文献

The AAA + ATPase Thorase is neuroprotective against ischemic injury.
AAA--ATPase Thorase 具有针对缺血性损伤的神经保护作用。
  • DOI:
    10.1177/0271678x18769770
    10.1177/0271678x18769770
  • 发表时间:
    2018
    2018
  • 期刊:
  • 影响因子:
    6.3
  • 作者:
    Jianmin Zhang;Jia Yang;Huaishan Wang;Omar Sherbini;Matthew J. Keuss;George K. E. Umanah;Emily Ling-Lin Pai;Zhikai Chi;Kaisa M. A. Paldanius;Wei He;Hong Wang;Shaida A. Andrabi;Ted M. Dawson;Valina L. Dawson
    Jianmin Zhang;Jia Yang;Huaishan Wang;Omar Sherbini;Matthew J. Keuss;George K. E. Umanah;Emily Ling-Lin Pai;Zhikai Chi;Kaisa M. A. Paldanius;Wei He;Hong Wang;Shaida A. Andrabi;Ted M. Dawson;Valina L. Dawson
  • 通讯作者:
    Valina L. Dawson
    Valina L. Dawson
共 1 条
  • 1
前往

Shaida A. Andrabi的其他基金

SULT4a1, a novel neuroprotective protein in stroke
SULT4a1,一种新型中风神经保护蛋白
  • 批准号:
    10308473
    10308473
  • 财政年份:
    2020
  • 资助金额:
    $ 40.84万
    $ 40.84万
  • 项目类别:
SULT4a1, a novel neuroprotective protein in stroke
SULT4a1,一种新型中风神经保护蛋白
  • 批准号:
    10527352
    10527352
  • 财政年份:
    2020
  • 资助金额:
    $ 40.84万
    $ 40.84万
  • 项目类别:
SULT4a1, a novel neuroprotective protein in stroke
SULT4a1,一种新型中风神经保护蛋白
  • 批准号:
    10096888
    10096888
  • 财政年份:
    2020
  • 资助金额:
    $ 40.84万
    $ 40.84万
  • 项目类别:
Poly (ADP-ribose) Mediates Cell Death in Stroke by Inhibiting Glucose Metabolism
聚(ADP-核糖)通过抑制葡萄糖代谢介导中风细胞死亡
  • 批准号:
    9261611
    9261611
  • 财政年份:
    2015
  • 资助金额:
    $ 40.84万
    $ 40.84万
  • 项目类别:
Poly (ADP-ribose) Mediates Cell Death in Stroke by Inhibiting Glucose Metabolism
聚(ADP-核糖)通过抑制葡萄糖代谢介导中风细胞死亡
  • 批准号:
    8962711
    8962711
  • 财政年份:
    2015
  • 资助金额:
    $ 40.84万
    $ 40.84万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
  • 批准号:
    10749539
    10749539
  • 财政年份:
    2024
  • 资助金额:
    $ 40.84万
    $ 40.84万
  • 项目类别:
MAIT cells in lupus skin disease and photosensitivity
MAIT 细胞在狼疮皮肤病和光敏性中的作用
  • 批准号:
    10556664
    10556664
  • 财政年份:
    2023
  • 资助金额:
    $ 40.84万
    $ 40.84万
  • 项目类别:
Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7
衰老对 CMT2B 相关 Rab7 驱动的神经元溶酶体损伤反应的影响
  • 批准号:
    10678789
    10678789
  • 财政年份:
    2023
  • 资助金额:
    $ 40.84万
    $ 40.84万
  • 项目类别:
The role of core circadian regulator Bmal1 in axonal regeneration and nerve repair
核心昼夜节律调节因子 Bmal1 在轴突再生和神经修复中的作用
  • 批准号:
    10677932
    10677932
  • 财政年份:
    2023
  • 资助金额:
    $ 40.84万
    $ 40.84万
  • 项目类别:
Translational Research and Implementation Science for Nurses (TRAIN) Program 2.0
护士转化研究和实施科学 (TRAIN) 计划 2.0
  • 批准号:
    10680769
    10680769
  • 财政年份:
    2023
  • 资助金额:
    $ 40.84万
    $ 40.84万
  • 项目类别: